A comprehensive view of Home Use / Self-Care. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Automobile Industry Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

An Italian study of patients accustomed to self-injecting drugs found that current procedures raise risk of error and contamination; issues included complex preparation procedures, difficulty drawing drug into syringe from vial, risk in use of the needle

Survey finds dramatic increase in demand for at-home diagnostic test kits over past two years; growth driven by rise in awareness of early diagnosis, increase in routine diagnosis, movement toward preventive care: R.R. Donnelley & Sons

FDA approves AstraZeneca and Amgen’s Tezspire tezepelumab in a pre-filled, single-use pen for patients aged 12 and older with severe asthma; Tezspire is the only biologic approved for severe asthma with no phenotype for use at home or doctor’s office

Health Canada approves Apex Labs’ take home psilocybin clinical trial; study to evaluate efficacy, safety, tolerability of APEX-52, a microdose, oral synthetic psilocybin drug product to treat depression, anxiety in adults diagnosed with PTSD

AstraZeneca’s Tezspire in new pre-filled pen approved for self-administration in EU for severe asthma patients aged 12 years and older; FDA approval on self-administration from pre-filled pen expected in first half of 2023

Ask us about our Automobile Industry market view

Trending Chart

Interactive chart with headline count